Noncanonical transforming growth factor beta signaling in scleroderma fibrosis
about
Cutaneous wound healing: recruiting developmental pathways for regenerationUpdate on scleroderma-associated interstitial lung diseaseWithaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivoTGF-β induces phosphorylation of phosphatase and tensin homolog: implications for fibrosis of the trabecular meshwork tissue in glaucomaCaveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung diseaseCombination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.FosB regulates stretch-induced expression of extracellular matrix proteins in smooth muscle.Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts.Caveolin-1 signaling in lung fibrosis.Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cellsEnhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog ExpressionRacial differences between blacks and whites with systemic sclerosisImatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro.The Role of TGF-β Receptors in Fibrosis.Fibroblast autophagy in fibrotic disorders.Transforming growth factor β--at the centre of systemic sclerosis.Hypoxia-sensitive pathways in inflammation-driven fibrosis.Functional autoantibodies in systemic sclerosis.Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models.TRPV4 ion channel is a novel regulator of dermal myofibroblast differentiation.Yin and Yang revisited: CCN3 as an anti-fibrotic therapeutic?Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment.PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosisFell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.Constitutive activation of c-Abl/protein kinase C-δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma.Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.Culture medium and cell density impact gene expression in normal skin and abnormal scar-derived fibroblasts.Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.
P2860
Q27004417-448AA19F-06DD-42CB-9BAC-14ACD6094932Q27016132-F80E9129-66B3-42DA-9B60-712C51594453Q28482173-65A88D5F-EFE8-4154-9B53-18738C506A6DQ33678064-822A67FF-58F5-422D-8BA1-18DEFC84ED76Q34154288-19B49575-F496-489E-BF74-E0272F191206Q34752957-F88D2FE5-0419-4AA2-9B5F-B59047BD028AQ35679510-A1306E99-F9C8-4E9A-B2F7-27574E8ACA06Q36054237-A89EB0D4-9241-46A8-82FC-B6E176E500FEQ36054245-0C1EE037-D7C0-48D3-9553-35AA973F4654Q36093857-B4CDD461-9F83-45CC-B072-C1C04D0674ACQ36529136-7E9C7FCB-5158-4A27-AC55-9F784B6C578DQ37052016-8715CB0C-E46D-4FE8-BE98-FC60D21A6ABBQ37129649-43555012-0C8D-4E53-8958-E1A2A8011FF2Q37386864-846C5F6B-7342-44EF-85A4-1320E4520407Q38026846-E038743D-DC62-479F-9C9D-4FF0BAE46B26Q38047232-25C70094-4B0E-4519-A811-E4393D54E27DQ38241227-C3623314-EF34-4955-9105-322E44389152Q38258327-D386873D-F540-409C-885C-37C1285AE3C5Q38570322-F6AAC36C-CF49-4A6D-8BCC-EDC625869193Q38788603-B7A74C9B-153E-41CF-A389-80F57F700FF5Q38935000-0D3082D0-5083-4343-9861-EB3BB6B05158Q40095940-1A451C54-166D-489B-B985-742F015372B1Q41347489-F6969130-9501-41E8-B804-5235406928A0Q42652598-55509DDD-5CF6-4D93-AA12-C091F213AA3BQ43763309-4703E312-5933-4881-BCDB-AB04B317E027Q44878948-EDDC2B7B-BD0B-420F-BA29-15D2D92F3751Q45304157-62662C48-9814-46FB-A7CB-660FFEF2F9E9Q47718418-67137DF0-5221-4F7E-932F-B9ABACF9D244Q52613671-A908CF7B-668F-435D-8323-B87818BA54F3Q54546815-E8CECFC0-90F5-419E-9303-528EAD673DB1
P2860
Noncanonical transforming growth factor beta signaling in scleroderma fibrosis
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Noncanonical transforming growth factor beta signaling in scleroderma fibrosis
@en
Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.
@nl
type
label
Noncanonical transforming growth factor beta signaling in scleroderma fibrosis
@en
Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.
@nl
prefLabel
Noncanonical transforming growth factor beta signaling in scleroderma fibrosis
@en
Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.
@nl
P2860
P1476
Noncanonical transforming growth factor beta signaling in scleroderma fibrosis
@en
P2860
P304
P356
10.1097/BOR.0B013E32833038CE
P577
2009-11-01T00:00:00Z